An Explainable MRI-Radiomic Quantum Neural Network to Differentiate Between Large Brain Metastases and High-Grade Glioma Using Quantum Annealing for Feature Selection.


Journal

Journal of digital imaging
ISSN: 1618-727X
Titre abrégé: J Digit Imaging
Pays: United States
ID NLM: 9100529

Informations de publication

Date de publication:
12 2023
Historique:
received: 19 04 2023
accepted: 17 07 2023
revised: 11 06 2023
medline: 23 10 2023
pubmed: 29 7 2023
entrez: 28 7 2023
Statut: ppublish

Résumé

Solitary large brain metastases (LBM) and high-grade gliomas (HGG) are sometimes hard to differentiate on MRI. The management differs significantly between these two entities, and non-invasive methods that help differentiate between them are eagerly needed to avoid potentially morbid biopsies and surgical procedures. We explore herein the performance and interpretability of an MRI-radiomics variational quantum neural network (QNN) using a quantum-annealing mutual-information (MI) feature selection approach. We retrospectively included 423 patients with HGG and LBM (> 2 cm) who had a contrast-enhanced T1-weighted (CE-T1) MRI between 2012 and 2019. After exclusion, 72 HGG and 129 LBM were kept. Tumors were manually segmented, and a 5-mm peri-tumoral ring was created. MRI images were pre-processed, and 1813 radiomic features were extracted. A set of best features based on MI was selected. MI and conditional-MI were embedded into a quadratic unconstrained binary optimization (QUBO) formulation that was mapped to an Ising-model and submitted to D'Wave's quantum annealer to solve for the best combination of 10 features. The 10 selected features were embedded into a 2-qubits QNN using PennyLane library. The model was evaluated for balanced-accuracy (bACC) and area under the receiver operating characteristic curve (ROC-AUC) on the test set. The model performance was benchmarked against two classical models: dense neural networks (DNN) and extreme gradient boosting (XGB). Shapley values were calculated to interpret sample-wise predictions on the test set. The best 10-feature combination included 6 tumor and 4 ring features. For QNN, DNN, and XGB, respectively, training ROC-AUC was 0.86, 0.95, and 0.94; test ROC-AUC was 0.76, 0.75, and 0.79; and test bACC was 0.74, 0.73, and 0.72. The two most influential features were tumor Laplacian-of-Gaussian-GLRLM-Entropy and sphericity. We developed an accurate interpretable QNN model with quantum-informed feature selection to differentiate between LBM and HGG on CE-T1 brain MRI. The model performance is comparable to state-of-the-art classical models.

Identifiants

pubmed: 37507581
doi: 10.1007/s10278-023-00886-x
pii: 10.1007/s10278-023-00886-x
pmc: PMC10584786
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2335-2346

Informations de copyright

© 2023. The Author(s).

Références

IEEE Signal Process Mag. 2019 Jan;36(1):164-173
pubmed: 31543691
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Nature. 2017 Oct 18;550(7676):375-379
pubmed: 29052620
Ann Oncol. 2021 Nov;32(11):1332-1347
pubmed: 34364998
J Pers Med. 2022 Feb 13;12(2):
pubmed: 35207763
Sci Rep. 2020 Jul 21;10(1):12110
pubmed: 32694637
Sci Rep. 2020 Jul 23;10(1):12340
pubmed: 32704007
Sci Rep. 2021 Feb 17;11(1):3973
pubmed: 33597610
Front Oncol. 2021 Jul 13;11:638262
pubmed: 34327133
J Clin Oncol. 2022 Feb 1;40(4):403-426
pubmed: 34898238
Rep Prog Phys. 2018 Jul;81(7):074001
pubmed: 29504942
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Oncotarget. 2016 Oct 18;7(42):69051-69059
pubmed: 27655705
Med Image Anal. 2017 Jan;35:303-312
pubmed: 27497072
Neuroradiology. 2015 Jul;57(7):697-703
pubmed: 25845813
Nat Commun. 2021 May 11;12(1):2631
pubmed: 33976136
Sci Rep. 2021 May 18;11(1):10478
pubmed: 34006893
Proc SPIE Int Soc Opt Eng. 2019 Mar;10949:
pubmed: 31551645
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186
pubmed: 33293629
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
Eur Radiol. 2018 Sep;28(9):3819-3831
pubmed: 29619517
Hum Brain Mapp. 2019 Dec 1;40(17):4952-4964
pubmed: 31403237
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Metabolites. 2022 Dec 14;12(12):
pubmed: 36557302
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
NMR Biomed. 2021 Apr;34(4):e4479
pubmed: 33448078
PLoS Med. 2018 Nov 30;15(11):e1002711
pubmed: 30500819
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Int J Comput Assist Radiol Surg. 2013 Sep;8(5):751-61
pubmed: 23334798
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95
pubmed: 36196752
AJNR Am J Neuroradiol. 2018 Jul;39(7):1208-1214
pubmed: 29724766
Acta Neurochir (Wien). 2010 Nov;152(11):1893-9
pubmed: 20799046
Nat Commun. 2022 Aug 22;13(1):4919
pubmed: 35995777
Cancers (Basel). 2022 Mar 08;14(6):
pubmed: 35326526
J Neuroradiol. 2020 May;47(3):197-202
pubmed: 30439396
Nature. 2017 Sep 13;549(7671):195-202
pubmed: 28905917
Soft comput. 2022 Apr 7;:1-20
pubmed: 35411203
Pract Radiat Oncol. 2022 Jul-Aug;12(4):265-282
pubmed: 35534352

Auteurs

Tony Felefly (T)

Radiation Oncology Department, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon. tony.felefly@hotmail.com.
ICube Laboratory, University of Strasbourg, Strasbourg, France. tony.felefly@hotmail.com.
Radiation Oncology Department, Hôtel-Dieu de Lévis, Lévis, QC, Canada. tony.felefly@hotmail.com.

Camille Roukoz (C)

Radiation Oncology Department, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.

Georges Fares (G)

Radiation Oncology Department, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.
Physics Department, Saint Joseph University, Beirut, Lebanon.

Samir Achkar (S)

Radiation Oncology Department, Gustave Roussy Cancer Campus, 94805, Villejuif, France.

Sandrine Yazbeck (S)

Department of Radiology, University of Maryland School of Medicine, 655 W Baltimore St S, Baltimore, MD, 21201, USA.

Philippe Meyer (P)

Medical Physics Department, Institut de Cancérologie de Strasbourg (ICANS), 67200, Strasbourg, France.
IMAGeS Unit, IRIS Platform, ICube, University of Strasbourg, 67085, Strasbourg Cedex, France.

Manal Kordahi (M)

Institut National de Pathologie, Beirut, Lebanon.

Fares Azoury (F)

Radiation Oncology Department, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.

Dolly Nehme Nasr (DN)

Radiation Oncology Department, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.

Elie Nasr (E)

Radiation Oncology Department, Hôtel-Dieu de France Hospital, Saint Joseph University, Beirut, Lebanon.

Georges Noël (G)

Radiotherapy Department, Institut de Cancérologie de Strasbourg (ICANS), 67200, Strasbourg, France.
Radiobiology Department, IMIS Unit, IRIS Platform, ICube, University of Strasbourg, 67085, Strasbourg Cedex, France.
Faculty of Medicine, University of Strasbourg, 67000, Strasbourg, France.

Ziad Francis (Z)

Physics Department, Saint Joseph University, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH